HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.

Abstract
SLC25A13 (citrin or aspartate-glutamate carrier 2) is located in the mitochondrial membrane in the liver and its genetic deficiency causes adult-onset type II citrullinemia (CTLN2). CTLN2 is one of the urea cycle disorders characterized by sudden-onset hyperammonemia due to reduced argininosuccinate synthase activity. This disorder is frequently accompanied with hepatosteatosis in the absence of obesity and ethanol consumption. However, the precise mechanism of steatogenesis remains unclear. The expression of genes associated with fatty acid (FA) and triglyceride (TG) metabolism was examined using liver samples obtained from 16 CTLN2 patients and compared with 7 healthy individuals. Although expression of hepatic genes associated with lipogenesis and TG hydrolysis was not changed, the mRNAs encoding enzymes/proteins involved in FA oxidation (carnitine palmitoyl-CoA transferase 1α, medium- and very-long-chain acyl-CoA dehydrogenases, and acyl-CoA oxidase 1), very-low-density lipoprotein secretion (microsomal TG transfer protein), and FA transport (CD36 and FA-binding protein 1), were markedly suppressed in CTLN2 patients. Serum concentrations of ketone bodies were also decreased in these patients, suggesting reduced mitochondrial β-oxidation activity. Consistent with these findings, the expression of peroxisome proliferator-activated receptor α (PPARα), a master regulator of hepatic lipid metabolism, was significantly down-regulated. Hepatic PPARα expression was inversely correlated with severity of steatosis and circulating ammonia and citrulline levels. Additionally, phosphorylation of c-Jun-N-terminal kinase was enhanced in CTLN2 livers, which was likely associated with lower hepatic PPARα. Collectively, down-regulation of PPARα is associated with steatogenesis in CTLN2 patients. These findings provide a novel link between urea cycle disorder, lipid metabolism, and PPARα.
AuthorsMichiharu Komatsu, Takefumi Kimura, Masahide Yazaki, Naoki Tanaka, Yang Yang, Takero Nakajima, Akira Horiuchi, Zhong-Ze Fang, Satoru Joshita, Akihiro Matsumoto, Takeji Umemura, Eiji Tanaka, Frank J Gonzalez, Shu-Ichi Ikeda, Toshifumi Aoyama
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1852 Issue 3 Pg. 473-81 (Mar 2015) ISSN: 0006-3002 [Print] Netherlands
PMID25533124 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Fatty Acids
  • Ketone Bodies
  • Mitochondrial Membrane Transport Proteins
  • PPAR alpha
  • RNA, Messenger
  • SLC25A13 protein, human
  • Triglycerides
  • JNK Mitogen-Activated Protein Kinases
Topics
  • Adult
  • Citrullinemia (complications, genetics, metabolism, pathology)
  • Down-Regulation
  • Fatty Acids (genetics, metabolism)
  • Fatty Liver (etiology, genetics, metabolism, pathology)
  • Female
  • Humans
  • JNK Mitogen-Activated Protein Kinases (genetics, metabolism)
  • Ketone Bodies (genetics, metabolism)
  • Lipid Metabolism
  • Male
  • Middle Aged
  • Mitochondria, Liver (genetics, metabolism, pathology)
  • Mitochondrial Membrane Transport Proteins
  • PPAR alpha (biosynthesis, genetics)
  • RNA, Messenger (biosynthesis, genetics)
  • Triglycerides (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: